Xing S, Shi S, Jin M, Han L, et al. Pembrolizumab-Chemotherapy Versus Pembrolizumab in Head and Neck Squamous Cell Carcinoma: A PD-L1 CPS-Stratified Analysis of Updated KEYNOTE-048 Data. Int J Cancer 2026 Jul 11. doi: 10.1002/ijc.70649.
PMID: 42433120